Related references
Note: Only part of the references are listed.Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection
Praveen P. N. Rao et al.
PHARMACEUTICALS (2021)
A high-throughput screening assay for dipeptidyl peptidase-IV inhibitors using human plasma
Jing Zhang et al.
ANALYTICAL METHODS (2021)
Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis
Rimesh Pal et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2021)
Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in inflammatory Bowel Disease
Pedro Pinto-Lopes et al.
INFLAMMATORY BOWEL DISEASES (2020)
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
Lihua Zhu et al.
CELL METABOLISM (2020)
Exposure to dipeptidyl-peptidase-4 inhibitors andCOVID-19 among people with type 2 diabetes: A case-control study
Gian Paolo Fadini et al.
DIABETES OBESITY & METABOLISM (2020)
Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications
Daniel J. Drucker
ENDOCRINE REVIEWS (2020)
Diagnostic utility of serum dipeptidyl peptidase (DPP- IV) /CD26 as a serum marker in Egyptian patients with colorectal cancer
Wafaa M. Elzefzafy et al.
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY (2020)
Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications
Adela Simkova et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
Yu Li et al.
ISCIENCE (2020)
Plant-derived peptides rubiscolin-6, soymorphin-6 and their c-terminal amide derivatives: Pharmacokinetic properties and biological activity
Azzurra Stefanucci et al.
JOURNAL OF FUNCTIONAL FOODS (2020)
Explorative Screening of Bioactivities Generated by Plant-Based Proteins after In Vitro Static Gastrointestinal Digestion
Camille Dugardin et al.
NUTRIENTS (2020)
Fabrication of a water-soluble near-infrared fluorescent probe for selective detection and imaging of dipeptidyl peptidase IV in biological systems
Xiumei Guo et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Accurate and sensitive detection of dipeptidyl peptidase-IV activity by liquid chromatography with fluorescence detection
Hong Ma et al.
ANALYTICAL METHODS (2020)
New tricks of prolyl oligopeptidase inhibitors - A common drug therapy for several neurodegenerative diseases
Reinis Svarcbahs et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Red Fluorescence Probe Targeted to Dipeptidylpeptidase-IV for Highly Sensitive Detection of Esophageal Cancer
Akira Ogasawara et al.
BIOCONJUGATE CHEMISTRY (2019)
Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention
Anastasia Loktev et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
CD26/DPP4-a potential biomarker and target for cancer therapy
Njanja Enz et al.
PHARMACOLOGY & THERAPEUTICS (2019)
The Discovery and Development of Liraglutide and Semaglutide
Lotte Bjerre Knudsen et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma
Shinichiro Watanabe et al.
CANCER BIOLOGY & THERAPY (2019)
Nanoformulations of natural products for management of metabolic syndrome
Yasamin Davatgaran Taghipour et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Anti-tumour effects of a xenogeneic fibroblast activation protein-based whole cell tumour vaccine in murine tumour models
Meihua Chen et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinoma
Marta Brunetti et al.
VIRCHOWS ARCHIV (2019)
Role of Milk-Derived Opioid Peptides and Proline Dipeptidyl Peptidase-4 in Autism Spectrum Disorders
Beata Jarmolowska et al.
NUTRIENTS (2019)
Fibroblast activation protein in liver fibrosis
Angelina J. Lay et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2019)
Fibroblast activation protein- promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways
Jun Jia et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein
Roger Yazbeck et al.
PROTOPLASMA (2018)
Activatable Near-Infrared Fluorescent Probe for Dipeptidyl Peptidase IV and Its Bioimaging Applications in Living Cells and Animals
Tao Liu et al.
ANALYTICAL CHEMISTRY (2018)
Glucagon-Like Peptide-1 (GLP-1)-Based Therapeutics: Current Status and Future Opportunities beyond Type2 Diabetes
Jia Ying Cheang et al.
CHEMMEDCHEM (2018)
Targeting fibroblast activation protein in cancer - Prospects and caveats
Petr Busek et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
Role of Alpha-Smooth Muscle Actin and Fibroblast Activation Protein Alpha in Ovarian Neoplasms
Ana Carolinne da Silva et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2018)
DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia
Darren C. Johnson et al.
NATURE MEDICINE (2018)
Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics
Ellen Pure et al.
ONCOGENE (2018)
Structures and mechanism of dipeptidyl peptidases 8 and 9, important players in cellular homeostasis and cancer
Breyan Ross et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Fibroblast activation protein in osteosarcoma cells promotes angiogenesis via AKT and ERK signaling pathways
Chao Zeng et al.
ONCOLOGY LETTERS (2018)
Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo
Reinis Svarcbahs et al.
SCIENTIFIC REPORTS (2018)
A novel fibroblast activation protein-targeted near-infrared fluorescent off-on probe for cancer cell detection, &ITin vitro&IT and &ITin vivo &ITimaging
Jie Xing et al.
JOURNAL OF MATERIALS CHEMISTRY B (2018)
Prolyl carboxypeptidase in Agouti-related Peptide neurons modulates food intake and body weight
Giuseppe Bruschetta et al.
MOLECULAR METABOLISM (2018)
Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/β-catenin pathway
Jiuyang Liu et al.
BMC CANCER (2018)
Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson's disease: historical overview and future prospects
Toshiharu Nagatsu
JOURNAL OF NEURAL TRANSMISSION (2017)
DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis
Marian C. Okondo et al.
NATURE CHEMICAL BIOLOGY (2017)
Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors
Katerina Babkova et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Biomarkers in Tumor Microenvironment? Upregulation of Fibroblast Activation Protein-α Correlates with Gastric Cancer Progression and Poor Prognosis
Mengmou Hu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2017)
Fibroblast Activation Protein-alpha-Positive Fibroblasts Promote Gastric Cancer Progression and Resistance to Immune Checkpoint Blockade
Xuyang Wen et al.
ONCOLOGY RESEARCH (2017)
Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?
Pekka T. Mannisto et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Development of a fluorogenic small substrate for dipeptidyl peptidase-4
Futa Ogawa et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2017)
Why is it so difficult to measure glucagon-like peptide-1 in a mouse?
Johanne A. Windelov et al.
DIABETOLOGIA (2017)
Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages
Cornelius Y. Taabazuing et al.
CELL CHEMICAL BIOLOGY (2017)
A highly specific ratiometric two-photon fluorescent probe to detect dipeptidyl peptidase IV in plasma and living systems
Li-Wei Zou et al.
BIOSENSORS & BIOELECTRONICS (2017)
Diabetes, hypertension, and chronic kidney disease progression: role of DPP4
Ravi Nistala et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Ultrasensitive Fluorescent Probes Reveal an Adverse Action of Dipeptide Peptidase IV and Fibroblast Activation Protein during Proliferation of Cancer Cells
Qiuyu Gong et al.
ANALYTICAL CHEMISTRY (2016)
Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics
Abraham Lopez et al.
CHEMBIOCHEM (2016)
A fluorescent switchable AIE probe for selective imaging of dipeptidyl peptidase-4 in vitro and in vivo and its application in screening DPP-4 inhibitors
Yi Wang et al.
CHEMICAL COMMUNICATIONS (2016)
Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins
L. Wagner et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
C. Klemann et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Dipeptidyl peptidase 9 enzymatic activity influences the expression of neonatal metabolic genes
Yiqian Chen et al.
EXPERIMENTAL CELL RESEARCH (2016)
Neuropeptide Y is a physiological substrate of fibroblast activation protein: Enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinoma
Pok Fai Wong et al.
PEPTIDES (2016)
Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model
Mingyao Meng et al.
TUMOR BIOLOGY (2016)
Fibroblast activation protein (FAP) as a novel metabolic target
Miguel Angel Sanchez-Garrido et al.
MOLECULAR METABOLISM (2016)
Rapid and sensitive detection of early esophageal squamous cell carcinoma with fluorescence probe targeting dipeptidylpeptidase IV
Haruna Onoyama et al.
SCIENTIFIC REPORTS (2016)
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes
Chris de Graaf et al.
PHARMACOLOGICAL REVIEWS (2016)
Animal models of Middle East respiratory syndrome coronavirus infection
Neeltje van Doremalen et al.
ANTIVIRAL RESEARCH (2015)
Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin
Hui Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Version 4.0 of PaxDb: Protein abundance data, integrated across model organisms, tissues, and cell-lines
Mingcong Wang et al.
PROTEOMICS (2015)
Structure of human dipeptidyl peptidase 10 (DPPY): a modulator of neuronal Kv4 channels
Gustavo Arruda Bezerra et al.
SCIENTIFIC REPORTS (2015)
Prolyl Oligopeptidase from the Blood Fluke Schistosoma mansoni: From Functional Analysis to Anti-schistosomal Inhibitors
Pavla Fajtova et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
The dipeptidyl peptidase family, prolyl oligopeptidase, and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis
Yannick Waumans et al.
FRONTIERS IN IMMUNOLOGY (2015)
DPP-4 inhibitors: a patent review (2012-2014)
Roberto Costante et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Prolyl Carboxypeptidase Activity Decline Correlates with Severity and Short-Term Outcome in Acute Ischemic Stroke
Kaat Kehoe et al.
NEUROCHEMICAL RESEARCH (2015)
Distribution, classification, domain architectures and evolution of prolyl oligopeptidases in prokaryotic lineages
Swati Kaushik et al.
BMC GENOMICS (2014)
Prolyl carboxypeptidase mRNA expression in the mouse brain
Jin Kwon Jeong et al.
BRAIN RESEARCH (2014)
DPP6 Domains Responsible for Its Localization and Function
Lin Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Dipeptidyl Peptidase IV as a Potential Target for Selective Prodrug Activation and Chemotherapeutic Action in Cancers
Arik Dahan et al.
MOLECULAR PHARMACEUTICS (2014)
Hypothalamic prolyl endopeptidase (PREP) regulates pancreatic insulin and glucagon secretion in mice
Jung Dae Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
Nobuya Inagaki et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Advances in Understanding the Expression and Function of Dipeptidyl Peptidase 8 and 9
Hui Zhang et al.
MOLECULAR CANCER RESEARCH (2013)
Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide's anti-leukemic activity
P. A. Spagnuolo et al.
LEUKEMIA (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
Targeted Inactivation of Dipeptidyl Peptidase 9 Enzymatic Activity Causes Mouse Neonate Lethality
Margaret G. Gall et al.
PLOS ONE (2013)
Dipeptidyl Peptidase 10, a Novel Prognostic Marker in Colorectal Cancer
Heae Surng Park et al.
YONSEI MEDICAL JOURNAL (2013)
Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
Kwon Wook Joo et al.
BMC NEPHROLOGY (2013)
Molecular dynamics, crystallography and mutagenesis studies on the substrate gating mechanism of prolyl oligopeptidase
Karol Kaszuba et al.
BIOCHIMIE (2012)
Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Tomohiro Yoshida et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Plasma Prolylcarboxypeptidase (Angiotensinase C) Is Increased in Obesity and Diabetes Mellitus and Related to Cardiovascular Dysfunction
Shengyuan Xu et al.
CLINICAL CHEMISTRY (2012)
Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease
Ai-li Sun et al.
DIABETES & VASCULAR DISEASE RESEARCH (2012)
Evaluation of the pharmacokinetic interaction between the dipeptidyl peptidase IV inhibitor LC15-0444 and pioglitazone in healthy volunteers
Sung Eun Kim et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2012)
Distribution of Prolyl Oligopeptidase in Human Peripheral Tissues and in Ovarian and Colorectal Tumors
Timo T. Myohanen et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Novel Serine Protease Dipeptidyl Peptidase IV Inhibitor: Alogliptin
Ritesh Agrawal et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
Structures of Human DPP7 Reveal the Molecular Basis of Specific Inhibition and the Architectural Diversity of Proline-Specific Peptidases
Gustavo Arruda Bezerra et al.
PLOS ONE (2012)
Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
Wei Jing Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease
Jonathan Z. Long et al.
CHEMICAL REVIEWS (2011)
Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α
Fiona M. Keane et al.
FEBS JOURNAL (2011)
Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Patrizio Mattei et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis and biological evaluation of bicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes
Tang Peng Cho et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
A Time-Resolved Fluorescence Probe for Dipeptidyl Peptidase 4 and Its Application in Inhibitor Screening
Mitsuyasu Kawaguchi et al.
CHEMISTRY-A EUROPEAN JOURNAL (2010)
Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial
H. M. R. Pattzi et al.
DIABETES OBESITY & METABOLISM (2010)
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Jofre Tenorio-Laranga et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Elucidating the Pathways of Degradation of Denagliptin
Biren K. Joshi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma
Ossama Abbas et al.
MODERN PATHOLOGY (2010)
The dimeric transmembrane domain of prolyl dipeptidase DPP-IV contributes to its quaternary structure and enzymatic activities
Kuei-Min Chung et al.
PROTEIN SCIENCE (2010)
Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase
Stephen M. Soisson et al.
BMC STRUCTURAL BIOLOGY (2010)
On the origin of serum CD26 and its altered concentration in cancer patients
Oscar J. Cordero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Emerging Drug Candidates of Dipeptidyl Peptidase IV (DPP IV) Inhibitor Class for the Treatment of Type 2 Diabetes
Rajesh Gupta et al.
CURRENT DRUG TARGETS (2009)
Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections
Aberra Fura et al.
DRUG METABOLISM AND DISPOSITION (2009)
Synthesis and use of 4-peptidylhydrazido-N-hexyl-1,8-naphthalimides as fluorogenic histochemical substrates for dipeptidyl peptidase IV and tripeptidyl peptidase I
Ivaylo Ivanov et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Prolylcarboxypeptidase: A cardioprotective enzyme
J. Mallela et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
The In Vivo Expression of Dipeptidyl Peptidases 8 and 9
Denise M. T. Yu et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen
Philip J. O'Reilly et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Seprase: An overview of an important matrix serine protease
Pamela O'Brien et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Serine peptidases: Classification, structure and function
M. J. Page et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Structure, Function and Biological Relevance of Prolyl Oligopeptidase
Laszlo Polgar et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2008)
(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors
Leo Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation
William J. Metzler et al.
PROTEIN SCIENCE (2008)
Selective fluorescence probes for dipeptidyl peptidase activity - Fibroblast activation protein and dipeptidyl peptidase IV
Koon Siew Lai et al.
BIOCONJUGATE CHEMISTRY (2007)
Dipeptidyl peptidase II (DPPII), a review
Marie-Berthe Maes et al.
CLINICA CHIMICA ACTA (2007)
Synthesis and structure-activity relationship of N-acyl-Gly-, N-acyl-Sar- and N-blocked-boroPro inhibitors of FAP, DPP4, and POP
Thuy Tran et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
On the role of prolyl oligopeptidase in health and disease
J. A. Garcia-Horsman et al.
NEUROPEPTIDES (2007)
E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo [4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor
Nobuyuki Yasuda et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Species and tissue differences in the expression of DPPY splicing variants
Koichi Takimoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Dipeptidyl peptidase II and leukocyte cell death
Marie-Berthe Maes et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Discovery, structure-activity relationship, and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors
Zhonghua Pei et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity
CY Edosada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly2-Pro1-cleaving specificity
CY Edosada et al.
FEBS LETTERS (2006)
Molecular characterization of a novel dipeptidyl peptidase like 2-short form (DPL2-s) that is highly expressed in the brain and lacks dipeptidyl peptidase activity
T Chen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2006)
Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative β-subunit of human cardiac transient outward current encoded by Kv4.3
S Radicke et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein α
K Aertgeerts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7)
MB Maes et al.
BIOCHEMICAL JOURNAL (2005)
Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes
B Ahrén et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer
Y Huang et al.
CANCER RESEARCH (2004)
Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation
K Aertgeerts et al.
PROTEIN SCIENCE (2004)
Recombinant prolylcarboxypeptidase activates plasma prekallikrein
Z Shariat-Madar et al.
BLOOD (2004)
Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface
WA Weihofen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Engineering a thermostable human prolyl endopeptidase for antibody-directed enzyme prodrug therapy
C Heinis et al.
BIOCHEMISTRY (2004)
Proyl peptidases: a serine protease subfamily with high potential for drug discovery
JS Rosenblum et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases
SY Qi et al.
BIOCHEMICAL JOURNAL (2003)
Seprase complexes in cellular invasiveness
WT Chen et al.
CANCER AND METASTASIS REVIEWS (2003)
Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites
S Lorey et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII
B Leiting et al.
BIOCHEMICAL JOURNAL (2003)
Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and α-melanocyte-stimulating hormone breakdown in the rat brain
G Bellemère et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection
MT Levy et al.
LIVER (2002)
Purification, molecular cloning, and immunohistochemical localization of dipeptidyl peptidase II from the rat kidney and its identity with quiescent cell proline dipeptidase
H Araki et al.
JOURNAL OF BIOCHEMISTRY (2001)
Molecular characterization of dipeptidyl peptidase activity in serum -: Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides
C Durinx et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
